AFP and neoplasm: In other studies, Halazun et al. demonstrated that a score using tumor size, AFP, and neutrophil-to-lymphocyte ratio successfully classified recipients according to the recurrence risk (four groups; low to very high), while Sasaki et al. integrated the tumor burden score and MELD-Na score as well as AFP [9,72].